Form 4: uniQure Director Kaye Jack Reports Acquisition of Shares and Stock Options

Director Kaye Jack reports acquisition of restricted share units and stock options in uniQure N.V.

Summary

• Director Kaye Jack reported acquiring 8,080 ordinary shares and 15,840 stock options in uniQure N.V. on June 19, 2024.
• The 8,080 ordinary shares were acquired through restricted share units granted under the Issuer's 2014 Share Incentive Plan, as amended and restated.
• Each restricted share unit represents the contingent right to receive one Ordinary Share and vests 100% on the first anniversary of the grant date, subject to continued relationship with the Issuer.
• The stock options, with an exercise price of $4.57, also vest 100% on the first anniversary of the grant date, subject to continued relationship with the Issuer.
• Following the transaction, Kaye Jack beneficially owns 14,581 ordinary shares and 15,840 stock options.

Sentiment

Score: 6

Explanation: The document is a neutral regulatory filing. The acquisition of shares and options by a director is generally a positive sign, indicating confidence in the company, but it's a routine event.

Positives

• The grant of restricted share units and stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service and commitment to the company's success.

Future Outlook

The restricted share units and stock options will vest on the first anniversary of the grant date, subject to the Reporting Person's continued relationship with the Issuer.

Industry Context

This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies. It reflects standard practices for incentivizing and retaining key personnel.

Comparison to Industry Standards

• Stock option and restricted share unit grants are common compensation tools in the biotechnology industry, used to align executive incentives with shareholder value.
• Companies like Amgen, Gilead Sciences, and Biogen also utilize similar equity-based compensation plans for their directors and executives.
• The vesting schedules and terms of these grants are generally consistent with industry norms, promoting long-term commitment and performance.

Stakeholder Impact

• The acquisition of shares and stock options by a director can be viewed positively by shareholders, as it aligns the director's interests with the company's performance.
• Employees may also view this as a positive sign, indicating confidence in the company's future.

Key Dates